11
Views
31
CrossRef citations to date
0
Altmetric
Article

Antagonistic Regulation of Cystic Fibrosis Transmembrane Conductance Regulator Cell Surface Expression by Protein Kinases WNK4 and Spleen Tyrosine Kinase

, , , , , & show all
Pages 4076-4086 | Received 01 Feb 2011, Accepted 22 Jul 2011, Published online: 20 Mar 2023
 

Abstract

Members of the WNK (with-no-lysine [K]) subfamily of protein kinases regulate various ion channels involved in sodium, potassium, and chloride homeostasis by either inducing their phosphorylation or regulating the number of channel proteins expressed at the cell surface. Here, we describe findings demonstrating that the cell surface expression of the cystic fibrosis transmembrane conductance regulator (CFTR) is also regulated by WNK4 in mammalian cells. This effect of WNK4 is independent of the presence of kinase and involves interaction with and inhibition of spleen tyrosine kinase (Syk), which phosphorylates Tyr512 in the first nucleotide-binding domain 1 (NBD1) of CFTR. Transfection of catalytically active Syk into CFTR-expressing baby hamster kidney cells reduces the cell surface expression of CFTR, whereas that of WNK4 promotes it. This is shown by biotinylation of cell surface proteins, immunofluorescence microscopy, and functional efflux assays. Mutation of Tyr512 to either glutamic acid or phenylalanine is sufficient to alter CFTR surface levels. In human airway epithelial cells, downregulation of endogenous Syk and WNK4 confirms their roles as physiologic regulators of CFTR surface expression. Together, our results show that Tyr512 phosphorylation is a novel signal regulating the prevalence of CFTR at the cell surface and that WNK4 and Syk perform an antagonistic role in this process.

ACKNOWLEDGMENTS

For kindly providing reagents used in this study, we thank H. König, (Karlsruhe, Germany) for Myc-hnRNP A1, X. Jeunemaître (Paris, France) for human WNK4 and WNK4-K174A cDNAs, Philip J. Thomas (University of Texas Southwestern Medical Center, Dallas, TX) and the CFTR Folding Consortium (CFF; Bethesda, MD) for recombinant NBD1 and vector pET-Sumo-NBD1, and J. P. Clancy (University of Alabama, Birmingham) for the wt-CFBE cell line.

This work was supported by the Portuguese Fundação para a Ciência e Tecnologia (grants POCI_PPCDT/SAU-MMO/56439/04 and PTDC/BIA-BCM/67058/06, Programa de Financiamento Plurianual do BioFIG (PEst-OE/BIA/UI4046/2011), and fellowships BD/23001/05 to A.I.M. and BPD/47445/08 to S.M.).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.